In our study, the expression levels of α-SMA mRNA and protein were increased compared with those in control group after TGF-β1 treatment, which was consistent with previous report [29], indicating that fibroblast-to-myofibroblast differentiation occurred, and could simulate the development of pulmonary fibrosis to some extent. The gene discussed is ACTA1; the disease is pulmonary fibrosis.